Key result
Advancing age was associated with lower odds of receiving aspirin (OR 0.67; 95% CI 0.51-0.89) and lipid-lowering medications (OR 0.14; 95% CI 0.08-0.25) before recurrent AMI.
Why the study?
What are the trends and determinants of receiving aspirin, beta-blockers, and lipid-lowering medications before recurrent acute MI in patients with a previous MI?
Observational (n=1,710)
Yes
What are the trends and determinants of receiving aspirin, beta-blockers, and lipid-lowering medications before recurrent acute MI in patients with a previous MI?
Despite increases over time, there remains significant underutilization of secondary prevention medications prior to recurrent MI, particularly among older patients and women.
No takes yet. Share an insight, caveat, or question.
May indicate undertreatment in older patients before recurrent MI; leaves open whether targeted strategies improve outcomes.
McCormick et al. (1999) conducted an observational in Recurrent acute myocardial infarction (n=1,710). Aspirin, beta-blockers, and lipid-lowering medications was evaluated on Receipt of aspirin, beta-blockers, and lipid-lowering medications before hospital admission for recurrent AMI. Advancing age was associated with lower odds of receiving aspirin (OR 0.67; 95% CI 0.51-0.89) and lipid-lowering medications (OR 0.14; 95% CI 0.08-0.25) before recurrent AMI.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: